Skip to main content

Table 2 Baseline and post-taping scores for tested variables in KT and placebo groups

From: Effects of kinesiotaping on disability and pain in patients with rotator cuff tendinopathy: double-blind randomized clinical trial

 

KT group

n = 25

Placebo group

n = 25

ANCOVA

baseline

Day 12

Day 30

p

baseline

Day 12

Day 30

P

p-Value

DASH

41.6 ± 10.84

33.16 ± 12.87

32.65 ± 13.9

0.001

44.55 ± 12.67

34.62 ± 16.68

34.65 ± 13.9

< 0.001

0.8

VASr

1.48 ± 1.75

0.72 ± 1.3

0.6 ± 1.08

0.012

1.64 ± 1.65

1.2 ± 1.35

1.12 ± 1.5

0.019

0.45

VASm

4.6 ± 0.81

3.16 ± 1.37

2.6 ± 1.41

< 0.001

4.6 ± 0,91

3.28 ± 1.64

3.44 ± 1.78

< 0.001

0.049

VASn

3.6 ± 1.97

2.68 ± 1.93

2.16 ± 1.79

< 0.001

3.8 ± 1.61

2.8 ± 1.63

2.48 ± 1.87

< 0.001

0.78

  1. DASH Disabilities of the Arm, Shoulder and Hand, VASr Visual Analog Scale for pain at rest, VASm Visual Analog Scale for pain during active movement, VASn Visual Analog Scale for pain at night